BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19879475)

  • 1. Radiation therapy for urologic malignancies in the elderly.
    Sandhu A; Mundt AJ
    Urol Oncol; 2009; 27(6):643-52. PubMed ID: 19879475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy and radiotherapy for urological cancer].
    Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies.
    Delaney G; Jacob S; Barton M
    Cancer; 2005 Feb; 103(3):462-73. PubMed ID: 15612081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy in the management of common genitourinary malignancies.
    Speight JL; Roach M
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):321-46. PubMed ID: 16730297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Johansson B; Ridderheim M; Glimelius B
    Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy of urologic cancer].
    Mikuriya S
    Gan No Rinsho; 1987 Mar; Spec No():405-15. PubMed ID: 3599440
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapeutic treatment of metastasized urological malignancies.
    van der Werf-Messing BH
    Prog Clin Biol Res; 1984; 153():577-83. PubMed ID: 6473413
    [No Abstract]   [Full Text] [Related]  

  • 8. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiation and/or surgery. Some areas of confrontation in urologic oncology.
    Whitmore WF
    Am J Clin Oncol; 1984 Dec; 7(6):595-606. PubMed ID: 6099052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urological cancers of the elderly subject: the role of radiotherapy].
    Hennequin C; Quéro L
    Prog Urol; 2009 Nov; 19 Suppl 3():S96-9. PubMed ID: 20123510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T1-T2 prostate cancer: treatment by radiation therapy].
    Lagrange JL; Guerif S
    Bull Cancer; 2007 Jul; 94(7 Suppl):F5-14. PubMed ID: 17845988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of imaging in the surveillance of urologic malignancies.
    Bradford TJ; Montie JE; Hafez KS
    Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of prostate cancer in the older man.
    Mohile SG; Lachs M; Dale W
    Semin Oncol; 2008 Dec; 35(6):597-617. PubMed ID: 19027464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum.
    Sajid S; Mohile SG; Szmulewitz R; Posadas E; Dale W
    Semin Oncol; 2011 Apr; 38(2):309-25. PubMed ID: 21421119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer in the elderly.
    Heinzer H; Steuber T
    Urol Oncol; 2009; 27(6):668-72. PubMed ID: 19879477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncogeriatric evaluation for elderly patients suffering from metastatic urologic malignancies].
    Neuzillet Y; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S415-25. PubMed ID: 19070825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.
    Hernandez J; Basler JW; Thompson IM
    Urol Clin North Am; 2004 May; 31(2):213-8. PubMed ID: 15123401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Systemic Therapy for Urologic Malignancies in Geriatric Patients.
    Zhao B; Grivas PD
    Clin Geriatr Med; 2015 Nov; 31(4):645-65. PubMed ID: 26476122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk and prophylactic management of bladder cancer after various forms of radiotherapy.
    Shirodkar SP; Kishore TA; Soloway MS
    Curr Opin Urol; 2009 Sep; 19(5):500-3. PubMed ID: 19553822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.